share_log

Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16

Benzinga ·  Dec 8, 2023 12:11

Craig-Hallum analyst Matt Hewitt maintains Avid Bioservices (NASDAQ:CDMO) with a Buy and lowers the price target from $22 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment